Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BBNX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 8,874 | $17.21 | $152.7K Sale | Form 4 ↗ |
| Nov 9, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 744 | $17.00 | $12.6K Sale | Form 4 ↗ |
| Nov 5, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 382 | $17.04 | $6,508 Sale | Form 4 ↗ |
| Nov 2, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 370 | $16.90 | $6,253 Sale | Form 4 ↗ |
| Oct 27, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 2,650 | $22.00 | $58.3K Sale | Form 4 ↗ |
| Oct 26, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 821 | $20.00 | $16.4K Sale | Form 4 ↗ |
| Oct 14, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 775 | $17.35 | $13.4K Sale | Form 4 ↗ |
| Sep 22, 2026 | Christy Jones Director | BBNX Beta Bionics, Inc. | Sale | 6,430 | $23.00 | $147.9K Sale | Form 4 ↗ |
| Sep 16, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 2,650 | $22.00 | $58.3K Sale | Form 4 ↗ |
| Sep 16, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 30,779 | $20.13 | $619.6K Sale | Form 4 ↗ |
| Sep 14, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 775 | $15.52 | $12.0K Sale | Form 4 ↗ |
| Sep 9, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 35,994 | $18.46 | $664.4K Sale | Form 4/A ↗ |
| Sep 3, 2026 | Sean Saint President & CEO, Director | BBNX Beta Bionics, Inc. | Sale | 5,641 | $20.08 | $113.3K Sale | Form 4 ↗ |
| Sep 2, 2026 | Steven Jon Russell Chief Medical Officer | BBNX Beta Bionics, Inc. | Sale | 4,221 | $19.11 | $80.7K Sale | Form 4 ↗ |
| Sep 2, 2026 | Sean Saint President & CEO, Director | BBNX Beta Bionics, Inc. | Sale | 16,867 | $19.11 | $322.3K Sale | Form 4 ↗ |
| Sep 2, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 6,675 | $19.11 | $127.6K Sale | Form 4 ↗ |
| Sep 2, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 4,375 | $19.11 | $83.6K Sale | Form 4 ↗ |
| Sep 2, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 5,327 | $19.11 | $101.8K Sale | Form 4 ↗ |
| Jun 29, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 4,896 | $17.03 | $83.4K Sale | Form 4/A ↗ |
| Jun 26, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 5,104 | $17.05 | $87.0K Sale | Form 4/A ↗ |
| Jun 24, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 1,258 | $15.01 | $18.9K Sale | Form 4 ↗ |
| Jun 24, 2026 | Christy Jones Director | BBNX Beta Bionics, Inc. | Sale | 1,406 | $15.00 | $21.1K Sale | Form 4 ↗ |
| Jun 4, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 275 | $12.31 | $3,385 Sale | Form 4 ↗ |
| Jun 4, 2026 | Christy Jones Director | BBNX Beta Bionics, Inc. | Sale | 2,811 | $14.00 | $39.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | Steven Jon Russell Chief Medical Officer | BBNX Beta Bionics, Inc. | Sale | 4,222 | $12.61 | $53.2K Sale | Form 4 ↗ |
| Jun 2, 2026 | Sean Saint President & CEO, Director | BBNX Beta Bionics, Inc. | Sale | 16,872 | $12.61 | $212.8K Sale | Form 4 ↗ |
| Jun 2, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 6,676 | $12.61 | $84.2K Sale | Form 4 ↗ |
| Jun 2, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 4,378 | $12.61 | $55.2K Sale | Form 4 ↗ |
| Jun 2, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 5,329 | $12.61 | $67.2K Sale | Form 4 ↗ |
| May 22, 2026 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 998 | $11.21 | $11.2K Sale | Form 4 ↗ |
| May 21, 2026 | Christy Jones Director | BBNX Beta Bionics, Inc. | Sale | 1,998 | $9.95 | $19.9K Sale | Form 4 ↗ |
| May 21, 2026 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 1,000 | $9.95 | $9,950 Sale | Form 4 ↗ |
| Mar 4, 2026 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 353 | $11.57 | $4,084 Sale | Form 4 ↗ |
| Jan 6, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 2,200 | $30.10 | $66.2K Sale | Form 4 ↗ |
| Jan 2, 2026 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 20,000 | $29.53 | $590.6K Sale | Form 4 ↗ |
| Jan 2, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 600 | $30.20 | $18.1K Sale | Form 4 ↗ |
| Jan 2, 2026 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 7,200 | $29.56 | $212.8K Sale | Form 4 ↗ |
| Dec 4, 2025 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 2,061 | $30.66 | $63.2K Sale | Form 4 ↗ |
| Dec 2, 2025 | Steven Jon Russell Chief Medical Officer | BBNX Beta Bionics, Inc. | Sale | 1,025 | $29.34 | $30.1K Sale | Form 4 ↗ |
| Dec 2, 2025 | Sean Saint President & CEO, Director | BBNX Beta Bionics, Inc. | Sale | 3,278 | $29.34 | $96.2K Sale | Form 4 ↗ |
| Dec 2, 2025 | Stephen Feider Chief Financial Officer | BBNX Beta Bionics, Inc. | Sale | 1,427 | $29.34 | $41.9K Sale | Form 4 ↗ |
| Dec 2, 2025 | Mike Mensinger Chief Product Officer | BBNX Beta Bionics, Inc. | Sale | 1,063 | $29.34 | $31.2K Sale | Form 4 ↗ |
| Dec 2, 2025 | Mark Hopman Chief Commercial Officer | BBNX Beta Bionics, Inc. | Sale | 856 | $29.34 | $25.1K Sale | Form 4 ↗ |
| Dec 1, 2025 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 500 | $29.91 | $15.0K Sale | Form 4 ↗ |
| Dec 1, 2025 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 906 | $29.35 | $26.6K Sale | Form 4 ↗ |
| Dec 1, 2025 | Maria Palasis Director | BBNX Beta Bionics, Inc. | Sale | 500 | $29.96 | $15.0K Sale | Form 4 ↗ |
| Dec 1, 2025 | Maria Palasis Director | BBNX Beta Bionics, Inc. | Sale | 906 | $29.33 | $26.6K Sale | Form 4 ↗ |
| Oct 31, 2025 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 38 | $27.70 | $1,053 Sale | Form 4 ↗ |
| Oct 31, 2025 | Adam Lezack Director | BBNX Beta Bionics, Inc. | Sale | 1,368 | $26.85 | $36.7K Sale | Form 4 ↗ |
| Oct 31, 2025 | Maria Palasis Director | BBNX Beta Bionics, Inc. | Sale | 119 | $27.45 | $3,267 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:47 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances